Exom - proud winner of the Business Excellence Award 2019“

Exom Group is pleased to announce that it received the Business Excellence Award 2019.


The Prize, promoted by the Harvard Business Review and the Italian Stock Exchange, is awarded to companies operating in Italy that have distinguished themselves with their outstanding performance in 2019. The reward honors the capacity for innovation, internationalization, growth, and management of human resources and talent.



Dr. Luigi Visani, CEO & President of Exom Group


“We are honored by the award.“ said Luigi Visani, MD – President and CEO of Exom Group. “Together with my valuable collaborators, we have been undertaking a project to modernize and simplify the complex processes of clinical drug development through the use of the most innovative digital technologies combined with qualified professional skills. Shortening the development time and reducing the operational costs, is a great benefit not only for study Sponsors. Patients benefit as well by gaining access to innovative treatments in a shorter time, starting with active participation in clinical studies.” Luigi Visani continued. “This award confirms the validity of our strategic vision and strengthens our determination to become the most innovative full-service global and digital CRO.“


About Exom
Exom is a Milan, Italy based CRO, which is committed to the modernization of Clinical Trials through Digital Transformation and Patient Engagement. By combining its expertise across medical, regulatory and operational functions with its proprietary, multi-modular and cloud based platform Genius SUITE™, Exom improves efficiencies and escalate process speeds while ensuring data quality and costs reduction, from Early Phase to Late & Outcome Studies.

Contact Information
Exom Group Srl
Viale F. Restelli 3/1
20124 Milan (Italy)
Ph. +39 02 36725581
Fax +39 02 36725580
info@exomgroup.com

Exom is the expert digital full-service CRO committed to the modernization of clinical trials through implementation of innovative digit... [mehr]